SCHEMBL23809353

SCHEMBL23809353

Cc1cc(C(C)C)c2c(c1)cc(C(=O)O)n2Cc1ccccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 4/20 0.44
HPGD P15428 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.41
GABRA5 P31644 2/20 0.40
GABRA1 P14867 1/20 0.40
GAA P10253 1/20 0.39
FDPS P14324 2/20 0.38
KMT2A Q03164 1/20 0.37
KDM4C Q9H3R0 1/20 0.37
FEN1 P39748 1/20 0.37
POLB P06746 1/20 0.37
ACHE P22303 1/20 0.37
BRD4 O60885 2/20 0.37
CCR2 P41597 1/20 0.36
GRIN1 Q05586 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23809474 0.90 ALDH1A1 (0.46) ALDH1A1KDM4EHPGDTSHRMAPK1
SCHEMBL23809222 0.90 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDTSHRMAPK1
SCHEMBL23809480 0.88 GPR35 (0.38) ALDH1A1KDM4EGAAFDPSKMT2A
SCHEMBL23809410 0.88 KDM4E (0.45) ALDH1A1KDM4EHPGDTSHRMAPK1
SCHEMBL26581294 0.86 KDM4E (0.45) ALDH1A1KDM4EHPGDTSHRMAPK1
SCHEMBL23809144 0.86 ALDH1A1 (0.45) ALDH1A1KDM4EHPGDTSHRMAPK1
SCHEMBL23809507 0.85 ALDH1A1 (0.37) ALDH1A1GAAFDPSKMT2ACCR2
SCHEMBL26036940 0.85 GPR35 (0.36) ALDH1A1KDM4EHPGDTSHRMAPK1
SCHEMBL26037331 0.85 SRD5A2 (0.45) ALDH1A1KDM4EHPGDTSHRMAPK1
SCHEMBL23809399 0.84 KDM4E (0.46) ALDH1A1KDM4EHPGDTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 ALDH1A1 2556/4885KDM4E 1156/4885HPGD 3190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.